










































American Journal Of Biomedical Science & Pharmaceutical Innovation 11 https://theusajournals.com/index.php/ajbspi 

 
 

 VOLUME Vol.05 Issue06 2025 

PAGE NO. 11-14 

DOI 10.37547/ajbspi/Volume05Issue06-03 

 
 
 
 

Analysis Of the Range Of Sedatives Registered In The 

Republic Of Uzbekistan 
 

Khasanov Farkhod Omonkulovich 

Assistant at Tashkent Pharmaceutical Institute, Tashkent city, Uzbekistan 

 

Kambarov Khusan Jahangirovich 

Professor, Doctor of Pharmaceutical Sciences, Tashkent Pharmaceutical Institute, Tashkent, Uzbekistan 

 

Ashurov Abdurahman Akbaraliyevich 

Director of the Tashkent Research Institute of Vaccines and Serums, Uzbekistan 

 

Received: 14 April 2025; Accepted: 10 May 2025; Published: 17 June 2025 

 

Abstract: This article analyzes the market of sedatives registered in the Republic of Uzbekistan. According to the 
State Register, the main share is accounted for by imported medicines, while the share of domestic manufacturers 
is about 10%. Most of the drugs registered in the country were imported from India, Pakistan, China, and Russia. 
The forms of medicines and market prices were also analyzed. 

 

Keywords: Sedatives, marketing analysis, State Register, dosage form, manufacturers, market analysis. 

 

Introduction: Accelerated development of the 
pharmaceutical industry, a significant increase in the 
volume of investments and exports attracted to the 
industry, as well as the introduction of a new 
management system to provide the population with 
high-quality, safe, and effective medicines [2]. 

Sedative drugs have a calming effect on the nervous 
system and are widely used in the treatment of stress, 
anxiety, and sleep disorders. Today, the demand for 
sedatives is growing among the population, as stress 
and mental fatigue are among the most common 
problems in the modern lifestyle[3]. 

Sedative medications affect the nervous system, 
helping to reduce stress and anxiety. According to the 
State Register in 2022-2025, there is a growing demand 
for this type of drug in Uzbekistan[1]. 

Analysis of registered sedative drugs in 2022-2025 

shows that domestic manufacturers are increasing 
their market share, but imports still remain a 
priority[4]. This article covers market analysis and 
development opportunities 

METHODS 

During the analysis, data from the State Register for 
2022-2025 and market analyses were studied. 
Manufacturers, dosage forms, and marketing 
strategies were evaluated using comparative analysis 
and statistical methods[1]. 

RESULTS 

According to the Register for 2022-2025, the main part 
of sedatives on the Uzbek market is supplied through 
imports. India, Pakistan, and China are the leaders, 
however, the share of domestic producers increased 
from 10% to 13%[1]. 

 

Table 1 

Analysis of sedative drugs by country of origin 

Manufacturing Countries 2022 (%)  2023 (%) 2024 (%) 2025 (%) 

India 21 20 18 17 

 

https://doi.org/10.37547/ajbspi/Volume05Issue06-03
https://doi.org/10.37547/ajbspi/Volume05Issue06-03


American Journal of Applied Science and Technology 12 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

Pakistan 15 14 14 13 

Chinese 13 13 12 11 

Russia 14 13 12 12 

Turkey 5 6 6 6 

USA 6 6 5 5 

Local manufacturers 10 11 13 13 

 

 

Figure 1. Share of countries producing sedatives in Uzbekistan (2025) 

This situation indicates a strong dependence on 
imports. The development of sedative production using 

local medicinal plants in Uzbekistan will help reduce 
import dependence. 

Analysis by dosage forms 

The distribution of registered sedatives by form in 2022-2025 is as follows[16]: 

Table 2. 

Drug form 2022 (%) 2023 (%) 2024 (%) 2025 (%) 

Syrups and tablets 50 48 47 46 

Capsules and 

dragees 

28 30 30 31 

Homeopathic 

infusions 

12 13 14 14 

Liquid extracts 10 9 9 9 

 

Analysis of sedative drugs by dosage forms in Uzbekistan (2025) 

Local manufacturers
17%

India; 22.1% 

Pakistan; 16.9%

China
14%

Russia
16%

Тurkey
8%

USA
6%



American Journal of Applied Science and Technology 13 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

 

Figure 2. Distribution of sedatives by forms in Uzbekistan

The analysis showed that domestic manufacturers 
mainly produce medicines in liquid and homeopathic 
forms. The main reason for this is that the technology 
for producing liquid preparations is much simpler and 
more economical. 

Price analysis 

During 2022-2025, prices in the sedative market ranged 
from 12,000 to 310,000 soums. 

• The cheapest preparations are from local 

manufacturers. 

• The most expensive drugs were imported from 
Germany, the USA, and Russia. 

The prices of three sedatives for 2025 were analyzed, 
as a result of which it was found that Modus is the most 
expensive (108,000 soums), and Central-B is the 
cheapest (59,000 soums). The price of Vamalyan is 
71,000 soums, which is in the middle range. These price 
differences can influence consumer choices[4]. 

 

Figure 3. Price of Sedatives (2025)

It was established that imported medicines are 2.5 - 4 
times more expensive than domestically produced 

medicines. 

Table 3. 

Cost of Sedatives (2025) 

Name of the drug Dosage form Average price (sum) 

Central-B Capsule 
59 000 

0

10

20

30

40

50

Syrups and tablets Capsules and dragees Homeopathic infusions Liquid extracts



American Journal of Applied Science and Technology 14 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

Name of the drug Dosage form Average price (sum) 

Mode Tablet 
108 000 

Vamelan Capsule 
71 000 

CONCLUSION 

According to the State Register of Registered Medicines 
and Medical Devices in the Republic of Uzbekistan for 
2022-2025, although domestic manufacturers have 
increased their market share, imports remain a priority. 
The share of domestic manufacturers is low, and mainly 
liquid medicines are produced. 

REFERENCES 

Approve the Resolution of the Ministry of Health of the 
Republic of Uzbekistan No. 26, 27, 28, 29 of the State 
Register of Medicines, Medical Devices and Medical 
Equipment Authorized for Use in Medical Practice of 
the Republic of Uzbekistan for 2022 - 2025. 

Decree of the President of the Republic of Uzbekistan, 
No. UP-13 (2025, January 28). 

Narzullaeva, I. B., & Kambarov, X. D. (2019). STUDYING 
THE ASSORTMENT OF SEDATIVE MEDICINES 
REGISTERED IN THE REPUBLIC OF UZBEKISTAN. In 
Economics, Business, Innovation (pp. 56-59). 

http://fom.uz. 

 


